张雨康, 牛丽娟, 刘隽颖. Advances in research on ultrasound-guided percutaneous ethanol injection for treatment of benign cystic thyroid nodules[J]. China Oncology, 2016, 26(1): 112-116.
张雨康, 牛丽娟, 刘隽颖. Advances in research on ultrasound-guided percutaneous ethanol injection for treatment of benign cystic thyroid nodules[J]. China Oncology, 2016, 26(1): 112-116. DOI: 10.3969/j.issn.1007-3969.2016.01.018.
Advances in research on ultrasound-guided percutaneous ethanol injection for treatment of benign cystic thyroid nodules
Because of development and popularization of the ultrasound techniques
the detection rate of nodal thyroid has increased. Surgery is the long-established therapeutic option. However
due to the surgical trauma
complications and the effect on quality of life
various minimally invasive treatments have been proposed and widely used. A large number of foreign studies have shown that ultrasound-guided percutaneous ethanol injection is a more commonly used minimally invasive way to treat benign pure cystic and predominantly cystic thyroid nodules. This article provides an up-to-date review of the overseas studies and summarized on percutaneous ethanol injection for the treatment of benign cystic thyroid nodules.
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Expert consensus on diagnosis and treatment of hematologic malignancies with solid tumors (2025 version)
MITF expression in acral melanoma tissues and its association with clinical, pathological characteristics and prognosis
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in ultrasound, CT, MRI and ablation of thyroid nodules and differentiated thyroid cancer
Analysis of clinical features, prognosis and comprehensive therapeutic strategies in 261 patients with limited-stage esophageal small cell carcinoma
Related Author
The Society of Breast Cancer China Anti-Cancer Association
Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
Multiple Primary and Unknown Primary Tumors Special Committee of China Anti-Cancer Association
Shanghai Anti Cancer Association Multiple Primary and Unknown Primary Tumor Special Committee
Lymphocytic Disease Group, Hematology Branch, Chinese Medical Association
Rare Disease Group, Hematology Branch, Chinese Medical Association
Tong WANG
Wei SUN
Related Institution
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
Department of Ultrasound, China-Japan Friendship Hospital
Japan Friendship Hospital (Institute of Clinical Medical Sciences), Peking Union Medical College, Chinese Academy of Medical Sciences,, China
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Center of Respiratory Medicine, China-Japan Friendship Hospital
Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Fudan University, Institute of Thoracic Oncology, Fudan University, Department of Oncology, Shanghai Medical College, Fudan University